Bioprojet

Ferrer Internacional, S.a.

Fundacion Centrol Nacional De Investigaciones Cardiovasculares Carlos Iii

Cnic Fundacion Centro Nacional De Investigaciones Cardiovasculares Carlos Iii

Fundacion Centro Nacional De Investigaciones Cardiovasculares Carlos Iii

Marta Guerrero

Jean-Charles Schwartz

Jeanne-Marie Lecomte

Antonio Guglietta

Xavier Ligneau

Walter Schunack

Manuel M Raga

Jean-Michel Arrang

Holger Stark

Juan Sallares

Charon Ganellin

Manel Raga

Pablo Martin

Anna Orriols

Manuel Raga

Alfonso Romero

Pablo MARTÍN

The invention relates to a capsule for the prevention of cardiovascular diseases which comprises coated tablets of acetylsalicylic acid, coated tablets of simvastatin or pravastatin, and coated tablets of lisinopril, ramiphl or perindopril. The capsules are used for the prevention of cardiovascular diseases in high-risk populations.

Capsule for the prevention of cardiovascular diseases

A method is provided for the treatment of sleep apnea and other conditions wherein an effective amount of crystalline 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine monohydrochloride of formula (I): optionally comprising water up to 6%, and having an X-ray diffractogram that comprises characteristic peaks (2&#x3b8;) at 11.2&#xb0;, 19.9&#xb0;, 20.7&#xb0; and 34.1&#xb0;&#xb1;0.2&#xb0; is administered to a patient in need thereof.

Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine

The invention relates to new crystalline 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine monohydrochloride, the respective manufacture and methods of use, and compositions containing such a compound.

Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine

Growing community of inventors

Barcelona, Spain

Marta Guerrero